tiprankstipranks
Humacyte (HUMA)
NASDAQ:HUMA
US Market

Humacyte (HUMA) Financial Statements

637 Followers

Humacyte Financial Overview

Humacyte's market cap is currently ―. The company's EPS TTM is $-1.008; its P/E ratio is -7.49; Humacyte is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -30.08M$ -23.39M$ -24.49M$ -21.00M$ -36.75M
EBITDA$ -28.25M$ -21.46M-$ -18.95M$ -34.27M
Net Income Common Stockholders$ -31.90M$ -25.14M$ -25.95M$ -22.71M$ -36.98M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 115.50M$ 80.45M$ 99.99M$ 114.60M$ 131.68M
Total Assets$ 161.47M$ 128.22M$ 149.38M$ 168.10M$ 182.98M
Total Debt$ 76.53M$ 57.51M$ 56.78M$ 56.32M$ 50.52M
Net Debt$ -38.98M$ -22.94M$ -43.21M$ -58.28M$ -81.16M
Total Liabilities$ 135.31M$ 114.68M$ 112.39M$ 107.03M$ 101.09M
Stockholders Equity$ 26.15M$ 13.55M$ 36.99M$ 61.13M$ 81.89M
Cash Flow-
Free Cash Flow$ -27.69M$ -19.15M-$ -19.55M$ -33.94M
Operating Cash Flow$ -27.30M$ -19.00M$ -13.10M$ -19.07M$ -32.79M
Investing Cash Flow$ -391.00K$ -150.00K$ -493.00K$ -1.98M$ 13.05M
Financing Cash Flow$ 62.80M$ -335.00K$ -764.00K$ 6.03M$ -409.00K
Currency in USD

Humacyte Earnings and Revenue History

Humacyte Debt to Assets

Humacyte Cash Flow

Humacyte Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis